Increase in hypothalamic cholecystokinin following acute and chronic morphine

Area of Science:

• Neuroscience
• Endocrinology
• Pharmacology

Background:

• Emerging evidence suggests an antagonistic relationship between cholecystokinin (CCK) and opiate peptides.
• Understanding this interaction is crucial for comprehending neurochemical signaling pathways.

Purpose of the Study:

• To investigate the impact of varying morphine administration levels on hypothalamic CCK levels.
• To determine the specific hypothalamic regions affected by morphine-induced changes in CCK.

Main Methods:

• Radioimmunoassay was employed to quantify CCK levels in whole hypothalamus and dissected hypothalamic subregions.
• Morphine administration was varied, including acute injections and chronic pellet implantation.

Main Results:

• Acute morphine sulfate (10 mg/kg) and single pellet implantation significantly elevated whole hypothalamic CCK levels.
• Chronic morphine exposure (multiple pellets or injections) did not lead to further increases in CCK.
• The observed increase in CCK was localized to the medial hypothalamus, sparing lateral and posterior regions.

Conclusions:

• Morphine administration modulates endogenous CCK levels within the hypothalamus.
• These findings support the hypothesis that CCK plays a role in mediating the physiological and behavioral effects of opiate peptides.